Found: 15
Select item for more details and to access through your institution.
Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6058, doi. 10.3390/ijms25116058
- By:
- Publication type:
- Article
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Body Mass Index, Sarcopenia, and Their Variations in Predicting Outcomes for Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 114, doi. 10.1159/000520833
- By:
- Publication type:
- Article
The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
- Published in:
- Oncology, 2016, v. 90, n. 2, p. 69, doi. 10.1159/000441148
- By:
- Publication type:
- Article
Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line.
- Published in:
- Oncology, 2015, v. 89, n. 6, p. 319, doi. 10.1159/000437230
- By:
- Publication type:
- Article
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
- Published in:
- Oncologist, 2024, v. 29, n. 7, p. 581, doi. 10.1093/oncolo/oyae019
- By:
- Publication type:
- Article
COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19).
- Published in:
- Clinical Medicine Insights: Oncology, 2022, p. 1, doi. 10.1177/11795549221090187
- By:
- Publication type:
- Article
Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 19, p. 6705, doi. 10.1002/cam4.4208
- By:
- Publication type:
- Article
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2332, doi. 10.1002/cam4.3806
- By:
- Publication type:
- Article
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19).
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4777, doi. 10.3390/cancers15194777
- By:
- Publication type:
- Article
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1742, doi. 10.3390/cancers15061742
- By:
- Publication type:
- Article
COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19).
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5547, doi. 10.3390/cancers14225547
- By:
- Publication type:
- Article
Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3389, doi. 10.3390/cancers13143389
- By:
- Publication type:
- Article
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer †.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 651, doi. 10.3390/pharmaceutics15020651
- By:
- Publication type:
- Article